Exits
NVM nets 3.6x return on e-know sale
NVM Private Equity has sold IT services firm e-know.net to AIM-listed cloud computing provider Nasstar for ТЃ13m.
Pembroke et al. buy Boat International Media from August Equity
An investment consortium led by Pembroke Venture Capital Trust has acquired publishing and events group Boat International Media from August Equity.
CVC sells Matas stake for $216m
CVC Capital Partners has sold its entire holding in Danish beauty retailer Matas for $216m (DKK 1.18bn), equating to 19.4% of the total share capital.
Deal in focus: VC-backed Okapi sold to US biopharma Aratana
The sale of venture-backed Belgian biopharmaceutical company Okapi Sciences to listed US biopharma Aratana Therapeutics highlights the benefits that come from maintaining relationships with former fellow investors.
Strong finish to the year for faltering emerging market
A turbulent year for CEE private equity is ending on a high. Kimberly Romaine reports
MBO Partenaires backs Cofigeo SBO
MBO Partenaires and Société Générale Capital Partenaires have acquired a stake in the buyout of French ready-meals specialist Cofigeo.
Gimv and Alsace acquire Wolf in SBO
Gimv and Alsace Capital have acquired French designer and manufacturer of women’s underwear Wolf Group from Cathay Capital and EPF Partners.
BDC's Mezzo di Pasta to change hands in Q1
Bridgepoint Development Capital-backed Mezzo di Pasta, a struggling French pasta fast food chain, is expected to be bought out of “redressement judiciaire” in February.
Credo Partners partially exits Lönne Holding
Credo Partners has sold LУЖnne Holding to Brammer, while simultaneously acquiring the group's subsidiary LУЖnne Service.
Inflexion reaps 3.5x on Optionis exit
Inflexion Private Equity has sold employment services company Optionis to MML Capital, realising a 3.5x multiple on its original investment.
VC-backed Okapi acquired by US biopharma Aratana
Belgian biopharmaceutical company Okapi Sciences, backed by several venture capital firms, has been acquired by listed US biopharma Aratana Therapeutics for a total consideration of up to €33.3m.
Turkven buys Carlyle's stake in Medical Park
Turkish private equity firm Turkven has acquired Carlyle’s 40% stake in hospital chain Medical Park.
Isis sells Kafevend to Eden Springs
Isis Equity Partners has sold Kafevend to Eden Springs, reaping a 2.5x multiple and an IRR of 13.8% for the Baronsmead VCTs.
Floating the idea of more Nordic IPOs
The Nordic IPO market, which has remained dormant for around five years, is emerging from its slumber. Karin Wasteson reports
VC-backed uniQure files $75m IPO
Dutch gene therapy company uniQure, backed by several venture capital firms, plans on raising up to $75m in its IPO on the Nasdaq.
Spie eyes IPO
French engineering company Spie, backed by Clayton Dubilier & Rice (CD&R) and Ardian, is considering a public listing by the end of the year.
News Corp pays €18m to boost video efforts
News Corp has bought Storyful, a Dublin-based social news agency backed by investors including ACT Venture Capital, for тЌ18m.
Westbridge Capital reaps 3x on Mobile Computing Systems
Westbridge Capital has sold its stake in software business Mobile Computing Systems (MCS), generating a 3x money multiple.
Arx reaps 4.5x on Ergis Eurofilms exit
Arx Equity Partners has divested Polish plastics processor Ergis Eurofilms through a series of block trades to investors on the Warsaw Stock Exchange.
Ardian sells Cegos stake
Ardian has divested its minority stake in French vocational training services business Cegos Group to management and existing shareholder Cegos Association.
FSN Capital sells Norman Shark
FSN Capital has divested Norman Shark, the malware analysis solutions division of its portfolio company Norman, to Blue Coat Systems.
Industrifonden sells Arcam shares
Industrifonden has partially exited its holding in listed 3D printing company Arcam via the sale of a 4.4% stake worth SEK 174m.
Deutsche Private Equity buys Zellbios from Ergon
Deutsche Private Equity (DPE) has acquired Luxembourg-based pharmaceuticals firm Zellbios from Ergon Capital Partners.